Case Report: Percutaneous closure of patent ductus arteriosus with the KONAR-MF™ device: initial experience and results at 6 months in a tertiary center

• by Alex Ismael Catalán Cabrera, Mónica Karem Medina Durand, Karen del Rosario Condori Alvino, Cesar Augusto Puma Laura, Norma Maribel Portilla Marroquin

• June 1, 2026

FDA Monthly Preview: Key July Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• June 26, 2026

• 5 min

Correction: Adenosine Dose and Cardioversion in Pediatric Supraventricular Tachycardia: A Systematic Review and Meta-Analysis

• by Laís dos Santos, Thaís Martins Shehan, Candela Lang, Ricardo Sanchez Algarin, Ingrid Bezerra de Oliveira Ribeiro, Paulo Cesar Mattos Dourado de Mesquita, Guilherme Dagostin de Carvalho

• July 4, 2026

Quality improvement: prevention of cardiac arrest in children with heart disease on the paediatric intensive care unit

• by Mark James Russell, Alison Jones, Susan Burlton, Rachael Morrison, David Ellis, Tim Jones, Natasha Khan, Hari Krishnan, Phil Botha

• July 14, 2026